清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score

医学 哮喘 背景(考古学) 组内相关 物理疗法 皮质类固醇 内科学 心理测量学 古生物学 临床心理学 生物
作者
Luís Pérez de Llano,Ignacio Dávila,Eva Martínez-Moragón,Javier Domínguez‐Ortega,Carlos Almonacid,C. Colás,Juan Luis García‐Rivero,Loreto Carmona,María Jesús García de Yébenes,Borja G. Cosío,Alfons Torregó,Alicia Habernau Mena,Antolín López-Viña,Antonio Parra Arrondo,Astrid Crespo‐Lessmann,Aythamy Henrquez Santana,Carolina Cisneros,César Picado,Cristian Domingo,Dario Antolin
出处
期刊:The Journal of Allergy and Clinical Immunology: In Practice [Elsevier BV]
卷期号:9 (7): 2725-2731 被引量:40
标识
DOI:10.1016/j.jaip.2021.01.033
摘要

Background There is a lack of tools to quantify the response to monoclonal antibodies (mAbs) holistically in severe uncontrolled asthma patients. Objective To develop a valid score to assist specialists in this clinical context. Methods The score was developed in four subsequent phases: (1) elaboration of the theoretical model of the construct intended to be measured (response to mAbs); (2) definition and selection of items and measurement instruments by Delphi survey; (3) weight assignment of the selected items by multicriteria decision analysis using the Potentially All Pairwise RanKings of All Possible Alternatives methodology using the 1000minds software; and (4) face validity assessment of the obtained score. Results Four core items, with different levels of response for each, were selected: severe exacerbations, oral corticosteroid use, symptoms (evaluated by Asthma Control Test), and bronchial obstruction (assessed by FEV1 percent predicted). Severe exacerbations and oral corticosteroid maintenance dose were weighted most heavily (38% each), followed by symptoms (13%) and FEV1 (11%). Higher scores in the weighted system indicate a better response and the range of responses runs from 0 (worsening) to 100 (best possible response). Face validity was high (intraclass correlation coefficient of 0.86). Conclusions The FEV1, exacerbations, oral corticosteroids, symptoms score allows clinicians to quantify response in severe uncontrolled asthma patients who are being treated with mAbs. There is a lack of tools to quantify the response to monoclonal antibodies (mAbs) holistically in severe uncontrolled asthma patients. To develop a valid score to assist specialists in this clinical context. The score was developed in four subsequent phases: (1) elaboration of the theoretical model of the construct intended to be measured (response to mAbs); (2) definition and selection of items and measurement instruments by Delphi survey; (3) weight assignment of the selected items by multicriteria decision analysis using the Potentially All Pairwise RanKings of All Possible Alternatives methodology using the 1000minds software; and (4) face validity assessment of the obtained score. Four core items, with different levels of response for each, were selected: severe exacerbations, oral corticosteroid use, symptoms (evaluated by Asthma Control Test), and bronchial obstruction (assessed by FEV1 percent predicted). Severe exacerbations and oral corticosteroid maintenance dose were weighted most heavily (38% each), followed by symptoms (13%) and FEV1 (11%). Higher scores in the weighted system indicate a better response and the range of responses runs from 0 (worsening) to 100 (best possible response). Face validity was high (intraclass correlation coefficient of 0.86). The FEV1, exacerbations, oral corticosteroids, symptoms score allows clinicians to quantify response in severe uncontrolled asthma patients who are being treated with mAbs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
感动的夏岚完成签到,获得积分10
4秒前
psm发布了新的文献求助10
7秒前
喜悦半莲完成签到,获得积分10
16秒前
psm完成签到 ,获得积分10
18秒前
40秒前
失眠的修杰完成签到,获得积分10
46秒前
49秒前
acat完成签到 ,获得积分10
49秒前
超级无敌万能小金毛完成签到,获得积分10
49秒前
52秒前
单薄涵梅完成签到,获得积分10
1分钟前
老戎完成签到 ,获得积分10
1分钟前
爱笑的笑旋完成签到,获得积分10
1分钟前
爆米花的应助被科研通管家采纳,获得10
1分钟前
nnn关闭了nnn的文献求助
1分钟前
科研民工完成签到,获得积分10
1分钟前
Zyou完成签到,获得积分10
1分钟前
落后的雨筠完成签到,获得积分10
1分钟前
2分钟前
大意的之柔完成签到,获得积分10
2分钟前
依然灬聆听完成签到,获得积分10
2分钟前
会发光的小叶子完成签到,获得积分10
2分钟前
漂亮傲云完成签到,获得积分10
2分钟前
勤劳寒松完成签到,获得积分10
2分钟前
风趣馒头完成签到,获得积分10
2分钟前
激动的发卡完成签到,获得积分10
3分钟前
李健的应助被科研通管家采纳,获得10
3分钟前
Maestro_S的应助被科研通管家采纳,获得10
3分钟前
null的应助被科研通管家采纳,获得10
3分钟前
时尚的青易完成签到,获得积分10
3分钟前
感性的鸡完成签到,获得积分10
3分钟前
嘻嘻完成签到,获得积分10
4分钟前
英俊的青烟完成签到,获得积分10
4分钟前
marine完成签到 ,获得积分10
4分钟前
4分钟前
向连虎发布了新的文献求助10
4分钟前
4分钟前
超级诗桃完成签到,获得积分10
5分钟前
绛仙旧友完成签到,获得积分10
5分钟前
无辜的水蜜桃完成签到,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166338
求助须知:如何正确求助?哪些是违规求助? 9559484
关于积分的说明 21750435
捐赠科研通 7757131
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553469
邀请新用户注册赠送积分活动 2473812